Evidence map›Paper›PMID 39417028›Full record

ArticleFrontiers in psychology2024

Mixing transcutaneous vagal nerve stimulation and galvanic cutaneous stimulation to decrease simulator adaptation syndrome.

Germán Gálvez-García, Patricio Mena-Chamorro, Tomás Espinoza-Palavicino, Tatiana Romero-Arias, Mauricio Barramuño-Medina, Claudio Bascour-Sandoval

Abstract read
In one paragraph

Article in Frontiers in psychology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Germán Gálvez-García *Departamento de Psicología, Universidad de La Frontera, Temuco, Chile.
Patricio Mena-Chamorro *Doctorado en Psicología, Universidad de La Frontera, Temuco, Chile.
Tomás Espinoza-PalavicinoDoctorado en Psicología, Universidad de La Frontera, Temuco, Chile.
Tatiana Romero-AriasFacultad de Ciencias de la Salud, Universidad Europea de Canarias, La Orotava, Spain.
Mauricio Barramuño-MedinaPrograma de Kinesiología, Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Temuco, Chile.
Claudio Bascour-SandovalDepartamento de Ciencias de la Rehabilitación, Universidad de La Frontera, Temuco, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Simulator Adaptation Syndrome arises from a perceptual discordance between expected and actual motion, giving rise to symptoms such as nausea and disorientation. This research focused on determining the benefit of Transcutaneous Vagal Nerve Stimulation (tVNS) and Galvanic Cutaneous Stimulation (GCS), where both were applied in conjunction, as compared to their administration in isolation, to decrease Simulator Adaptation Syndrome (SAS). Method: A driving simulation study was proposed where SAS, body balance, and driving performance were measured. These measurements were taken during seven different stimulation scenarios with a baseline condition without stimulation compared against tVNS and GCS conditions. Results: The main result showed that the combination of tVNS and GCS reduced SAS and improved body balance and driving performance more successfully than their administration in isolation. Conclusion: Similar neuromodulation in the temporoparietal junction is proposed to mitigate SAS for GCS and tVNS (although additional explanations are discussed). Applying both techniques simultaneously is encouraged to decrease SAS in future interventions.

Indexed as

galvanic cutaneous stimulationmotion sicknessneurostimulationsimulator adaptation syndrometranscutaneous vagal nerve stimulation

Identifiers

PMID39417028
PMCPMC11479896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.